Knygos.lt klubas Knygos.lt nariams
304,35 €
-30%
Įprastai
434,79 €
Drug Discovery for Leishmaniasis
Drug Discovery for Leishmaniasis
Knygos.lt klubas Knygos.lt nariams
304,35 €
-30%
Įprastai
434,79 €
  • Išsiųsime per 12–18 d.d.
From a human health perspective, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Between 10 and 12 million people are affected by the disease and with no known vaccine, the development of new drugs is urgently required. This volume provides a perspective of current treatments and their challenges as well as discussing emerging strategies and methodologies that will drive new drug development for this 'neglected' disease.
  • Leidėjas:
  • ISBN-10: 1782628894
  • ISBN-13: 9781782628897
  • Formatas: 16.3 x 23.4 x 2.8 cm, kieti viršeliai
  • Kalba: Anglų

Drug Discovery for Leishmaniasis (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

From a human health perspective, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Between 10 and 12 million people are affected by the disease and with no known vaccine, the development of new drugs is urgently required. This volume provides a perspective of current treatments and their challenges as well as discussing emerging strategies and methodologies that will drive new drug development for this 'neglected' disease.

Knygos.lt klubas
Knygos.lt nariams
304,35 €
-30%
Įprastai
434,79 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 4,35 Knygų Eurų!?
Išsiųsime per 12–18 d.d.
Įsigykite dovanų kuponą
Daugiau
  • Leidėjas:
  • ISBN-10: 1782628894
  • ISBN-13: 9781782628897
  • Formatas: 16.3 x 23.4 x 2.8 cm, kieti viršeliai
  • Kalba: Anglų

From a human health perspective, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Between 10 and 12 million people are affected by the disease and with no known vaccine, the development of new drugs is urgently required. This volume provides a perspective of current treatments and their challenges as well as discussing emerging strategies and methodologies that will drive new drug development for this 'neglected' disease.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)